EVA Live, Inc. (Nasdaq: GOAI), an AI-driven digital advertising company, announces the official launch of NeuroServe, its next-generation online advertising platform built to help advertisers improve performance, reduce inefficiencies in A/B testing and manual errors , and scale campaigns more efficiently using artificial real-time learning intelligence. This equates to a higher rate of return for marketing budgets.
NeuroServe has been in development for more than two years and was BETA tested with online advertisers and lead generators in 2025. The platform was built from the ground up to operate at enterprise scale and improve advertising performance without the complexity and delays of traditional campaign management.
Using real-time AI learning, NeuroServe continuously analyzes how users interact with ads and automatically adjusts delivery and targeting as campaigns run. This approach replaces slow, manual optimization with instant decision-making, reducing human error, accelerating campaign performance, and redefining traditional digital marketing workflows.
Key benefits of NeuroServe include:
- Real-time AI-driven optimization across campaigns
- Higher-quality traffic and lead generation
- Improved return on ad spend with reduced waste
- Automated optimization without manual testing
- Built to support high-volume advertising at scale
The platform was stress-tested with select agencies and lead-generation partners to validate performance, stability, and scalability under real-world traffic conditions.
According to industry research from Grand View Research, the global online advertising market is estimated at approximately $500 billion in 2025 and is projected to grow to more than $1.3 trillion by the early 2030s, driven by e-commerce growth, mobile adoption, and increased use of AI-driven advertising technologies.
NeuroServe is positioned to become EVA Live’s core revenue-generating product. Based on early demand, platform scalability, and market opportunity, management expects NeuroServe to represent a growing share of EVA Live’s overall revenue and to become the Company’s leading product by sales by the end of 2026, subject to market conditions and execution.
NeuroServe is now available to online businesses, and live demonstrations can be requested through EVA Live’s website at eva.live/nueroserve. The Company has expanded its engineering, product, and go-to-market teams with experienced industry professionals to support platform scalability.
